Cwm LLC Buys 10,699 Shares of SPDR S&P Biotech ETF $XBI

Cwm LLC grew its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 77.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 24,492 shares of the exchange traded fund’s stock after acquiring an additional 10,699 shares during the quarter. Cwm LLC’s holdings in SPDR S&P Biotech ETF were worth $2,986,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Pursue Wealth Partners LLC boosted its holdings in SPDR S&P Biotech ETF by 5.9% in the fourth quarter. Pursue Wealth Partners LLC now owns 11,679 shares of the exchange traded fund’s stock worth $1,424,000 after purchasing an additional 646 shares during the last quarter. PFG Investments LLC grew its position in SPDR S&P Biotech ETF by 9.4% in the 4th quarter. PFG Investments LLC now owns 14,404 shares of the exchange traded fund’s stock worth $1,756,000 after purchasing an additional 1,241 shares during the period. Invested Advisors raised its stake in SPDR S&P Biotech ETF by 63.4% during the 4th quarter. Invested Advisors now owns 8,888 shares of the exchange traded fund’s stock valued at $1,084,000 after buying an additional 3,447 shares during the last quarter. BCS Private Wealth Management Inc. raised its stake in SPDR S&P Biotech ETF by 0.8% during the 4th quarter. BCS Private Wealth Management Inc. now owns 36,828 shares of the exchange traded fund’s stock valued at $4,490,000 after buying an additional 282 shares during the last quarter. Finally, Farther Finance Advisors LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 24.6% during the 4th quarter. Farther Finance Advisors LLC now owns 9,379 shares of the exchange traded fund’s stock valued at $1,144,000 after buying an additional 1,849 shares during the period.

SPDR S&P Biotech ETF Price Performance

XBI stock opened at $134.49 on Friday. The company has a market cap of $8.73 billion, a P/E ratio of 11.47 and a beta of 0.88. SPDR S&P Biotech ETF has a 1 year low of $75.68 and a 1 year high of $139.19. The stock’s fifty day moving average price is $127.28 and its 200-day moving average price is $121.69.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.